FDA Approves First New Children’s ADHD Drug in 10 Years
TUESDAY, April 6, 2021 (HealthDay News) — The first new drug developed in over a decade for children with attention deficit hyperactivity disorder (ADHD) has been approved by the U.S. Food and Drug Administration. Qelbree, also known as viloxazine, comes in a capsule that is taken daily, and is notContinue Reading










